Patience David 4
4 · TriSalus Life Sciences, Inc. · Filed Aug 15, 2025
Insider Transaction Report
Form 4
Patience David
Chief Financial Officer
Transactions
- Award
Common Stock
2025-08-14+200,000→ 200,000 total - Award
Employee Stock Option (right to buy)
2025-08-14+290,000→ 290,000 totalExercise: $3.88Exp: 2035-08-13→ Common Stock (290,000 underlying)
Footnotes (2)
- [F1]Represents grant of restricted stock units (the "RSU Award") payable solely in common stock of the Issuer. The shares subject to the RSU Award vest in four equal annual installments commencing on July 1, 2026, subject to the Reporting Person's continued service with the Issuer on each respective vesting date.
- [F2]One-fourth (1/4th) of the shares subject to the option shall vest on the one-year anniversary of the vesting commencement date of July 1, 2026 (the "VCD"), and 1/36th of the remaining shares shall vest each month thereafter on the same day of the month as the VCD (or if there is no corresponding day, on the last day of the month), subject to the Reporting Person's continuous service with the Issuer on each respective vesting date.